InVivo Therapeutics, based in Cambridge, MA, is a pioneering brand that is redefining the treatment of spinal cord injury. With a strong focus on rapid intervention, they offer innovative technology designed to support cell survival and growth. Their mission is to improve the lives of patients by providing effective treatment options for spinal cord injury.

InVivo Therapeutics is committed to advancing the field of spinal cord injury treatment through their robust pipeline of products. They offer cutting-edge solutions that address the unmet needs of patients and families, as well as physicians seeking better treatment options. As a brand, InVivo Therapeutics values transparency and accountability.

They provide detailed information through press releases, presentations, and SEC filings, ensuring that investors and the media are kept informed of their progress. Their commitment to corporate governance is evident in their comprehensive governance documents and committee composition. Discover how InVivo Therapeutics is revolutionizing spinal cord injury treatment through their pioneering technology.

Explore their website for the latest news and updates on their mission to redefine the treatment of spinal cord injury